Literature DB >> 3392585

Iodine-131-labeled fibronectin: potential agent for imaging atherosclerotic lesion and thrombus.

A Uehara1, Y Isaka, K Hashikawa, K Kimura, T Kozuka, T Kamada, H Etani, S Yoneda, M Imaizumi.   

Abstract

Fibronectin is known to interact with fibrin, collagen, etc. We have labeled fibronectin with 131I, and measured its accumulation in the deendothelialized lesion in the rabbit aorta to evaluate it as a candidate for imaging atherosclerotic lesions and thrombi. Accumulation of [131I] fibronectin in the deendothelialized lesion was apparent at 48 hr, and increased at 72 hr after injection of the agent. Our results indicate that radiolabeled fibronectin may be a useful tracer for imaging early atherosclerotic lesion and thrombus.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3392585

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  3 in total

Review 1.  Nuclear medicine and atherosclerosis.

Authors:  H Sinzinger; I Virgolini
Journal:  Eur J Nucl Med       Date:  1990

2.  Progression of detail.

Authors: 
Journal:  J Nucl Cardiol       Date:  2000-03       Impact factor: 5.952

3.  In vivo molecular imaging of acute and subacute thrombosis using a fibrin-binding magnetic resonance imaging contrast agent.

Authors:  René M Botnar; Alexandra S Perez; Sonia Witte; Andrea J Wiethoff; James Laredo; James Hamilton; William Quist; Edward C Parsons; Anand Vaidya; Andrew Kolodziej; John A Barrett; Philip B Graham; Robert M Weisskoff; Warren J Manning; Michael T Johnstone
Journal:  Circulation       Date:  2004-04-05       Impact factor: 29.690

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.